Skip to search form
Skip to main content
Skip to account menu
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
Morphine Sulfate 20 MG Extended Release Oral Capsule [Kadian]
Known as:
MORPHINE SULFATE 20 mg ORAL CAPSULE, EXTENDED RELEASE [KADIAN]
, Kadian 20 MG Extended Release Oral Capsule
, MS 20 MG Extended Release Oral Capsule [Kadian]
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
21 relations
Extended Release Oral Capsule
Gelatin
Kadian
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
High-Alert Medications
C. Blank
2017
Corpus ID: 80126965
High-alert drugs pose a significant threat to patient safety. There are safeguards that pharmacists should put in place to reduce…
Expand
2011
2011
The Relative Bioavailability of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules (EMBEDA®) and an Extended Release Morphine Sulfate Capsule Formulation (KADIAN®) in Healthy…
F. Johnson
,
S. Ciric
,
S. Boudriau
,
J. Kisicki
,
Joseph W. Stauffer
American journal of therapeutics
2011
Corpus ID: 3137753
Morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®, King Pharmaceuticals®, Inc., Bristol, TN…
Expand
2007
2007
(758): In vivo pharmacokinetics of KADIAN® (morphine sulfate extended-release) capsules taken with alcohol
S. Sun
,
F. Johnson
,
Joseph W. Stauffer
,
G. Wagner
2007
Corpus ID: 79429376
2005
2005
A head-to-head, single-dose trial of KADIAN® vs AVINZA® 30mg in healthy, opioid-naïve subjects in the fed state: Comparison of pharmacokinetics
M. Royal
2005
Corpus ID: 74020086
2005
2005
Treatment of neuropathic pain with KADIAN® in poor responders to other pain medications
B. Nicholson
,
J. Sasaki
,
A. Weil
,
E. Ross
2005
Corpus ID: 58523730
2004
2004
Opioids in non-cancer pain: Improved quality of life with Kadian® (morphine sulfate sustained-release capsules) in patients with chronic, non-malignant, moderate/severe pain: The KRONUS-MSP trial
E. Ross
,
J. Sasaki
,
A. Weil
,
B. Nicholson
2004
Corpus ID: 79430109
2004
2004
Opioids in non-cancer pain: Kadian® (morphine sulfate sustained-release capsules) is effective and safe for elderly patients with chronic, non-malignant, moderate/severe pain: The KRONUS-MSP trial
J. Sasaki
,
A. Weil
,
B. Nicholson
,
E. Ross
2004
Corpus ID: 79552207
2000
2000
A Patient Preference Study Comparing Two Extended-Release Morphine Sulfate Formulations (Once-Daily Kadian® versus Twice-Daily MS Contin®) for Cancer Pain
R. Kerr
,
W. Tester
2000
Corpus ID: 71460156
AbstractObjective: To compare pain control, patient preference and tolerability for two extended-release ® capsules (administered…
Expand
Highly Cited
1997
Highly Cited
1997
Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain.
A. Broomhead
,
R. Kerr
,
+4 authors
P. Hodsman
Journal of pain and symptom management
1997
Corpus ID: 23221409
Kadian/Kapanol (K) is a capsule formulation of morphine designed for 12- or 24-hourly dosing. This double-blind study compared…
Expand
1997
1997
Comparative Bioavailability of Sustained-Release Morphine Sulfate Capsules versus Pellets
A. Broomhead
,
R. West
,
Gaithry Kadirgamanathan
,
Kaye Knox
,
Don Krueger
,
J. Malick
1997
Corpus ID: 72492911
SummaryKadian™ is an oral formulation of sustained-release morphine sulfate pellets contained in a gelatin capsule, indicated for…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE